Eva Pharma is one of the leading and fastest growing pharmaceutical manufacturers in the MENA region, with a 30%+ CAGR over the past five years. It is a branded generics powerhouse which also operates in OTC and food supplements. Eva Pharma has a portfolio of over 126 products; covering various therapeutic classes including Neurology, Psychiatry, Cardiovascular, Orthopedics, GIT, Pediatrics, Urology and Dermatology. The company has its own sales teams in many countries of the MENA region including Egypt, KSA, UAE, Bahrain, Qatar, Oman, Kuwait, Iraq, Lebanon, Yemen, Kenya, Libya & Ethiopia. Its distinctive state-of-the-art manufacturing facility in Cairo is approved by EMA, SFDA & GCC authorities allowing it to be a contract manufacturer for some of the leading companies in the globe. Eva Pharma is led by a distinctive team of professionals with a forward thinking philosophy, it continues to add local and international manufacturing facilities wherever opportunities arise and is growing strategically to ensure its high quality affordable products are available for all.
Contact
Armanious Group Tower, 9 El Sharekat Street, Opera – Abdeen, Cairo, Egypt
Concerted efforts are, at last, being made to redraw the rulebook and tidy up a local regulatory landscape long renowned for its torpor, dysfunction and ineffectuality. The Egyptian pharmaceutical market…
In an exclusive discussion with Focus Reports, Egyptian Minister of Health, Dr. Ahmed El Din Rady sets out his blueprint for improving the nation’s welfare and securing positive public health…
Ten years after his first interview with Focus Reports, Wafik Bardissi discusses Minapharm’s position as the leading biosimilar manufacturer in the Middle East. Has Egypt taken steps to incentivize the development or registration…
Fresenius Kabi’s general manager for the MENA region discusses evolving attitudes towards clinical nutrition for critically ill patients and Egypt’s positioning as a knowledge center and source of medical professionals…
Former Egyptian Minister of Health Adel Adawy discusses the reforms needed in the Egyptian healthcare system and the progress made in the fight against HCV over the last two years.…
Japanese company Otsuka envisioned Egypt as a hub for its Middle East and African operations as early as 1995. The president of the local subsidiary discusses the current activities of…
Oncology already represents the second largest portion of Egypt’s public healthcare budget, and despite limited public funding, demand for and acceptance of innovation is high, according to Roche’s regional general…
While growth forecasts for the MENA region remain high, falling oil prices and political instability are creating significant government budgetary challenges for the industry to adapt to. Janssen’s area managing…
“My primary concern is not the current economic situation, but rather the fact that there does not appear to be a clear vision for how Egypt can overcome these challenges…
The founder of the Middle East’s largest pharmaceutical company, EIPICO, discusses the evolution of the Egyptian pharmaceutical industry over the last 50 years, and his hopes for the industry over…
Eva Pharma is one of the fastest growing pharmaceutical companies in the MENA region, and CEO Riad Armanious is aiming to take the company from the 21st ranked generic company…
After choosing Egypt as the first country to host a production plant in the Middle East, AstraZeneca is interested in strengthening its foothold in the market. The country president discusses…